Yahoo News: Cancer

Finding the right games to play during the worst time in your life

Sat, 03/14/2015 - 20:06
Gaming can be an effective, even empowering escape for people of all ages undergoing cancer treatment — but how do you find the right types of games to play to get away? Panelist Eddie Gonzalez-Novoa, the executive director for The Survivor Games, explained that working with hospitals to equip their cancer treatment centers with gaming equipment and connecting gaming survivors is an important ...

Idaho lawmakers approve limits on indoor tanning by teens

Fri, 03/13/2015 - 20:03
By Laura Zuckerman SALMON, Idaho (Reuters) - Idaho lawmakers have passed a bill banning indoor tanning for children under 13 and requiring parental consent for those aged 14 to 18 to address the state's rising skin cancer rate. The bill, which must still be signed or vetoed by the governor, passed the Idaho legislature this week after emotional testimony from skin cancer survivors and pleas by ...

Two-thirds in U.S. with invasive cancer live five or more years: study

Thu, 03/12/2015 - 19:34
Two out of three people in the United States with cancer that has spread to nearby tissue live at least five years after they are diagnosed, according to a federal study released on Thursday. The U.S. Centers for Disease Control and Prevention tracked patients diagnosed from 2003 to 2010 and found that the overall five-year survival rate for invasive cancer was 65 percent. Five-year survival ...

Cancer Genetics reports 4Q loss

Thu, 03/12/2015 - 12:10
On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 55 cents. Losses, adjusted for costs related to mergers and acquisitions, came to 49 cents per share. The diagnostics ...

Online offers of personalized cancer medicine may not be trustworthy

Wed, 03/11/2015 - 22:03
By Janice Neumann (Reuters Health) - Tumor tests, genetic risk analyses and other products or services sold online as personalized cancer medicine are often not backed by evidence, according to a new U.S. study. “It’s hard to know which are which.” Gray, who is also an assistant professor of medicine at Harvard Medical School, said she and a coauthor had noticed that many of their patients asked ...

Study: Tetanus shot may aid treatment of deadly brain cancer

Wed, 03/11/2015 - 18:40
NEW YORK (AP) — Can a tetanus shot help treat brain cancer? A small study hints that it might.

Sloan Kettering to build cancer center near Nassau Coliseum

Wed, 03/11/2015 - 10:32
Memorial Sloan Kettering Cancer Center plans to build an outpatient treatment and research facility on Long Island near the Nassau Coliseum. Nassau County Executive Edward Mangano will announce in his ...

Merck cancer drug is first approved under UK early access scheme

Wed, 03/11/2015 - 07:51
Merck & Co's cancer drug Keytruda, which works by boosting the immune system but has yet to be licensed in Europe, is the first medicine to be made available to patients in Britain under a new early access scheme. The Medicines and Healthcare Products Regulatory Agency said on Wednesday that the treatment had been cleared to treat adults and children from 12 years of age with advanced melanoma ...

More evidence breast cancer and prostate cancer cluster in families

Tue, 03/10/2015 - 19:39
(In para 15 (3rd para from bottom), corrects attribution of quote by changing "she said" to "Beebe-Dimmer said".) By Kathryn Doyle (Reuters Health) - Women with close male relatives with prostate cancer are more likely to be diagnosed with breast cancer, a new study confirms. These findings, from the large Women's Health Initiative, reinforce the results of a 1994 study in the Journal of the ...

FDA approves United Therapeutics' drug for treating cancer in children

Tue, 03/10/2015 - 16:51
(Reuters) - The Food and Drug Administration said it approved United Therapeutics Corp's drug to treat neuroblastoma, a rare cancer that typically occurs in children below 5 years. Unituxin is the first drug approved to treat high-risk neuroblastoma patients who have a greater chance of tumors recurring or progressing after chemotherapy.

Cancer is in remission for teen forced to undergo chemo

Mon, 03/09/2015 - 21:56
HARTFORD, Conn. (AP) — A 17-year-old Connecticut girl who was forced to undergo chemotherapy by the state after she and her mother refused treatment is happy her cancer is in remission but still upset she had no choice in the matter.

More evidence breast cancer and prostate cancer cluster in families

Mon, 03/09/2015 - 16:57
By Kathryn Doyle (Reuters Health) - Women with close male relatives with prostate cancer are more likely to be diagnosed with breast cancer, a new study confirms. These findings, from the large Women's Health Initiative, reinforce the results of a 1994 study in the Journal of the National Cancer Institute, the authors write. “This is not the first study to examine this relationship, but it is ...

CTI BioPharma blood cancer drug meets main goal in trial

Mon, 03/09/2015 - 11:19
(Reuters) - CTI BioPharma Corp said its experimental blood cancer treatment achieved the main goal of a late-stage study. Data from the study showed that the drug, pacritinib, was significantly better than the "best available therapy" as prescribed by the patients' physician to treat myelofibrosis. Myelofibrosis is a form of blood cancer that makes the bone marrow produce too much of any type of ...

Cancer death comes weeks after NYC man's hospice wedding

Sat, 03/07/2015 - 22:42
NEW YORK (AP) — A 26-year-old man with a rare form of cancer has died less than two months after marrying his longtime girlfriend at a New York City hospice.

Prenatal blood tests detect cancer signal in some women

Thu, 03/05/2015 - 21:09
By Julie Steenhuysen LA JOLLA, Calif. (Reuters) - A new genetic test that sequences the blood of pregnant women for signs of diseases such as Down Syndrome in their fetuses are turning up unexpected results: a diagnosis of cancer in the mother. In as many as 40 cases, women who took Sequenom Inc's MaterniT21 test, which scans their genetic code and that of their fetus, had abnormal changes that ...

AbbVie boosts cancer drug pipeline with $21 billion Pharmacyclics deal

Thu, 03/05/2015 - 19:15
AbbVie Inc is to buy Pharmacyclics Inc for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. The deal -- the latest example of a big drugmaker swooping on a biotech firm to refill its medicine pipeline -- confounds expectations that Pharmacyclics would sell out to Johnson & Johnson ...

Wear blue on Friday to raise colon cancer awareness

Thu, 03/05/2015 - 15:35
By Daniel Gaitan (Reuters Health) - Advocates hope that people with colorectal cancer and their caregivers will dress in blue on Friday to raise awareness about the disease, which is the second-leading cancer-related cause of death in the U.S. Each year on the first Friday in March, supporters hold “Dress in Blue Day” to encourage more Americans to be tested for the disease. In 2000, President ...

J&J nearing deal to buy cancer drug maker Pharmacyclics: FT

Wed, 03/04/2015 - 23:31
Johnson & Johnson is close to buying cancer drug maker Pharmacyclics Inc in the coming days, the Financial Times reported, citing sources. A bid from J&J is expected to value Pharmacyclics near its $17.5 billion market value or at a premium, FT said on Wednesday, citing people familiar with the matter. Shares of Pharmacyclics, which markets blood cancer drug Imbruvica with J&J's Janssen unit ...

Head of U.S. National Cancer Institute to step down

Wed, 03/04/2015 - 22:37
The director of the U.S. National Cancer Institute will step down later this month after nearly five years at the helm of the agency that supports basic research on cancer in academia, industry, and its own labs, the National Institutes of Health announced on Wednesday. Dr. Harold Varmus's resignation will be effective on March 31. Dr. Douglas Lowy, currently the deputy director, will become ...

Treatment for prostate cancer varies by area of U.S

Wed, 03/04/2015 - 21:58
By Kathryn Doyle (Reuters Health) - A new study of Medicare and private insurance claims confirms that treatment trends for localized prostate cancer differ by U.S. region, by state and even from county to county. “There are several treatment options for men with localized prostate cancer,” said lead author Dr. K. Clinton Cary of the urology department at Indiana University School of Medicine in ...